This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Zhongbin Chen in mRNA Vaccine Development
Introduction
Zhongbin Chen is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of vaccine development, particularly in the area of mRNA technology. His work is crucial in the ongoing efforts to combat viral infections.
Latest Patents
Zhongbin Chen holds a patent for the "HERPES ZOSTER mRNA VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF." This innovative approach aims to enhance the effectiveness of vaccines against herpes zoster, showcasing his commitment to advancing medical science.
Career Highlights
Zhongbin Chen is associated with Hangzhou Tianlong Pharmaceutical Co., Ltd., where he collaborates with a team of dedicated professionals. His expertise in mRNA technology positions him as a key player in the pharmaceutical industry.
Collaborations
He works alongside talented colleagues such as Gengshen Song and Kai Dong, contributing to a collaborative environment that fosters innovation and research.
Conclusion
Zhongbin Chen's work in mRNA vaccine development represents a significant advancement in medical technology. His contributions are vital in the fight against viral diseases, and his ongoing research promises to yield further breakthroughs in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile